Getein Biotech, Inc (SHA:603387)
7.96
-0.10 (-1.24%)
Jun 11, 2026, 1:24 PM CST
Getein Biotech Market Cap
Getein Biotech has a market cap or net worth of 4.09 billion as of June 10, 2026. Its market cap has decreased by -0.62% in one year.
Market Cap
4.09B
Enterprise Value
3.45B
Revenue
1.08B
Ranking
n/a
PE Ratio
18.32
Stock Price
7.96
Market Cap Chart
Since July 17, 2017, Getein Biotech's market cap has decreased from 4.23B to 4.09B, a decrease of -3.35%. That is a compound annual growth rate of -0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 4.09B | -3.70% |
| Dec 31, 2025 | 4.24B | 1.45% |
| Dec 31, 2024 | 4.18B | -25.00% |
| Dec 29, 2023 | 5.58B | -12.00% |
| Dec 30, 2022 | 6.34B | -12.61% |
| Dec 31, 2021 | 7.25B | -18.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Lifotronic Technology | 4.74B |
| Shanghai Sanyou Medical | 4.63B |
| Hangzhou AGS MedTech | 4.43B |
| Contec Medical Systems Co.,Ltd | 4.37B |
| Shanghai Kinetic Medical | 4.37B |
| Nanjing Medlander Medical Technology | 4.29B |
| GKHT Medical Technology | 4.24B |
| Guangdong Biolight Meditech | 4.14B |